Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe

BACKGROUND: A multi-centre field trial was conducted to evaluate the efficacy of afoxolaner based chewables (NexGard® or NexGard Spectra®) for the treatment of generalised demodicosis caused by Demodex canis in dogs under field conditions in France, Italy and Poland. METHODS: Client-owned dogs, diag...

Descripción completa

Detalles Bibliográficos
Autores principales: Lebon, Wilfried, Beccati, Massimo, Bourdeau, Patrick, Brement, Thomas, Bruet, Vincent, Cekiera, Agnieszka, Crosaz, Odile, Darmon, Céline, Guillot, Jacques, Mosca, Marion, Pin, Didier, Popiel, Jaroslaw, Pomorska Handwerker, Dorota, Larsen, Diane, Tielemans, Eric, Beugnet, Frédéric, Halos, Lénaïg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131853/
https://www.ncbi.nlm.nih.gov/pubmed/30201031
http://dx.doi.org/10.1186/s13071-018-3083-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131853/
https://www.ncbi.nlm.nih.gov/pubmed/30201031
http://dx.doi.org/10.1186/s13071-018-3083-2

Ejemplares similares